Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SERRATHOR
NCT03867695Terminated
- Sponsor
- Strasbourg University Hospital
- Start
- Sep 2019
- Primary completion
- Oct 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of ropivacaine in postoperative pain (2 arms), sponsored by Strasbourg University Hospital. Primary endpoint: Total intravenous morphine consumption at 24 hours. Started Sep 2019; status: terminated.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03867695.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03867695.